Home > Stocks > Commentaries
Beneficiaries of the new Farm Bill
Over the long run, the Agriculture Act of 2014 (new Farm Bill) should enable farmers and equipment makers to operate in a favorable environment. Moreover, it is part of an initiative intended to expand and grow markets for local products around the world. Read more
Krispy Kreme and its Coffee Competition
Two years ago, we presented a comparison between the business models of Krispy Kreme and Dunkin’ Brands Group. At the time, Krispy Kreme had changed its strategy after a tumultuous decade in which overly aggressive expansion led to numerous difficulties including failing franchises and gargantuan losses and debt. Read more
Retail Roundup: November 26, 2014
Retail sales showed some improvement in the month of October, providing much needed confidence as we head into the ever-important Holiday Season. Indeed, with Black Friday just a couple days away, many retailers are hoping that a healthy holiday push will make up for what has been an otherwise sluggish year on the retail front. Companies mentioned in this review include Wal-Mart, Target, J.C. Penney, Amazon.com, Urban Outfitters, Abercrombie & Fitch, Michael Kors, and The Gap. Read more
Drug Roundup: November 21, 2014
There have been several noteworthy developments in the drug space recently, which will likely have a material impact on the companies in this sector and the markets they serve. Companies mentioned in this review include Actavis plc. (ACT), Allergan Inc. (AGN), Valeant Pharmaceuticals (VRX), Zoetis Inc. (ZTS), Pfizer Inc. (PFE), Merck & Co. (MRK), and AstraZeneca PLC (AZN). Read more
Bank And Thrift Mergers to Continue
More bank and thrift mergers are inevitable, despite a recent slowdown in the trend. Read more
Drug Roundup: October 16, 2014
There have been several noteworthy developments in the drug space recently, which will likely have a material impact on the companies in this sector and the markets they serve. Companies mentioned in this review include Eli Lilly & Co. (LLY), Bristol-Myers Squibb (BMY), Merck & Co. (MRK), Pfizer Inc. (PFE), Actavis plc. (ACT), AbbVie Inc. (ABBV), and Shire plc. (SHPG). Read more
Dogs Of The Dow: 2014 Third Quarter Review
The equity bull market is now somewhat long in the tooth and, as it makes its way through its sixth straight year, the going has not been as easy as it was in the early part of this run. The Dow Jones Industrials have posted solid, if relatively unexciting, numbers through the first three quarters, but the Dogs have maintained an edge throughout most of that period. Read more
Restaurant Roundup: October 9, 2014
There are a handful of companies in the restaurant space that do not report results on a calendar-year basis, so we will take a look at their recent performances to try and get a better picture of what is to come in the next few weeks. Read more
The Great International Expansion of Gaming

Gaming’s growth in Macau, China has made many Asian countries envious. Eager to replicate the success of the world’s biggest gaming market, a number of nations in the Pacific region have/are contemplating the approval for integrated casino resorts.  None of them offer the potential of Japan, whose population possess high earnings and have a proclivity for gaming. Moreover, should the economic juggernaut approve the building of such establishments, it is apt to attract gaming enterprises from across the world.

Read more
Technology Round Up: October 2, 2014

There have been several noteworthy developments in the technology space recently. Some of these will likely have a material impact on the companies in the sector and the markets they serve. Companies featured include Sony (SNE), Apple (AAPL), Samsung, and eBay (EBAY).

 

Read more
[First] [Previous] [Next] [last]
Loading...
Free stock reports
The Value Line 600
Value Line is regarded as the best independent research available. More than just recommendations, Value Line provides the rationale behind its picks for greater understanding.
- Don D., California